LyndseyNRunaasMD

Oncology • Milwaukee, WI

Physician

Join to view full profile

Dr. Runaas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Runaas' full profile

Already have an account?

Office
9200 W Wisconsin Ave
Milwaukee, WI 53226
Phone+1 414-805-4600

Fax+1 414-805-6815

Education & Training

University of MichiganFellowship, Hematology and Medical Oncology, 2014 - 2017
University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 2010 - 2013
University of Wisconsin School of Medicine & Public HealthClass of 2010

Certifications & Licensure

WI State Medical License 2012 - 2025
MI State Medical License 2014 - 2018
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Tildrakizumab for Prevention of Acute Graft-Versus-Host Disease Start of enrollment: 2020 Mar 01
Active, not recruiting
Phase 2

Publications & Presentations

PubMed

40 is the new 50: reducing the need for platelet transfusions prior to lumbar puncture in adults with hematologic malignancies.
Kristen Corrao, Adrian Umpierrez, Angela Treml, Aniko Szabo, Laura Michaelis
Haematologica. 2025-01-30
Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703.
Shernan G Holtan, Javier Bolaños-Meade, Monzr M Al Malki, Juan Wu, Carrie L Kitko
Journal of Clinical Oncology. 2025-01-03
4 citations
A phase I study of pevonedistat, azacitidine, and venetoclax in patients with relapsed/refractory acute myeloid leukemia.
Guru Subramanian Guru Murthy, Antoine N Saliba, Aniko Szabo, Alexandra Harrington, Sameem Abedin
Haematologica. 2024-09-01

Abstracts/Posters

A Multisite Phase Ib Study of Pevonedistat, Azacitidine and Venetoclax (PAVE) for the Treatment of Subjects with Acute Myelogenous Leukemia (AML)
Lyndsey Runaas, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lintuzumab Ac-225 in Combination with CLAG-M Chemotherapy in Relapsed/Refractory AML: Interim Results of a Phase I Study
Lyndsey Runaas, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

Systematic Screening for Familial Leukemia Based on Somatic Genomic Profiling Results
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Reducing Venous Thrombosis with Antithrombin Supplementation in Patients Undergoing Treatment for ALL with Asparaginase Based Regimens
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018